A new study reports that people taking GLP-1 drugs in daily life don’t lose as much weight as those in clinical trials who ...

CHICAGO -- Adding investigational cagrilintide to a GLP-1 receptor agonist increased weight loss in adults with obesity with ...

GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...

Overweight patients given an experimental weight loss drug being developed by China's Sciwind Biosciences lost an average of ...

Adults with overweight or obesity who received once-weekly ecnoglutide, a novel GLP-1 receptor agonist, had superior and ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

The American College of Cardiology (ACC) gave popular obesity medications equal standing with diet and exercise as a ...

A novel weight loss drug in the same class as semaglutide has successfully met its targets in its largest clinical trial yet, ...

Former FDA chief Dr. David Kessler says the new weight-loss drugs are a powerful tool to fight obesity. But they come with ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

Here are eight takeaways from our conversation with Kessler about using the GLP-1 drugs, and the changing landscape of weight loss. Foods high in salt, sugar and fat that are "highly palatable and ...